EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Evaluating the predictive value of late gadolinium enhancement assessed by cardiac magnetic resonance on sudden cardiac death in patients selected for implantable cardioverter defibrillator and cardiac resynchronization therapy implantation: a systematic review and meta-analysis

Richárd Masszi, Előd-János Zsigmond, Réka Ehrenberger, Caner Turan, Péter Fehérvári, Brigitta Teutsch, Zsolt Molnár, Zsófia Drobni, Hajnalka Vágó, Péter Hegyi, Béla Merkely, Annamária Kosztin

Clinical Research in Cardiology · 2024

DOI: 10.1007/s00392-024-02441-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Research in Cardiology, 2024. Verfasst von Richárd Masszi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Medicine, Semmelweis University, Budapest, 1085, Hungary. Hauptthemen laut MEDLINE: Death, Sudden, Cardiac, Defibrillators, Implantable, Cardiac Resynchronization Therapy, Contrast Media. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Semmelweis Egyetem, Nemzeti Kutatási Fejlesztési és Innovációs Hivatal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance (CMR) can evaluate myocardial scar associated with a higher risk of sudden cardiac death (SCD), which can guide the selection between cardiac resynchronization therapy with or without a defibrillator (CRT-P/CRT-D). Our aim was to investigate the association between LGE and SCD risk in patients with CRT using the LGE-CMR technique. Methods and results We performed a systematic literature search using four databases. The target population was CRT candidates. The primary endpoint was SCD. The risk of bias was assessed using the QUIPS tool. Fifteen eligible articles were included with a total of 2494 patients, of whom 27%, 56%, and 19% had an implantable cardioverter defibrillator (ICD), CRT-D, and CRT-P, respectively. Altogether, 54.71% of the cohort was LGE positive, who had a 72% higher risk for SCD (HR 1.72; 95% CI 1.18–2.50) compared to LGE negatives. In non-ischemic patients, the proportion of LGE positivity was 46.6%, with a significantly higher risk for SCD as compared to LGE negatives (HR 2.42; 95% CI 1.99–2.94). The subgroup of CRT-only patients showed no difference between the LGE-positive vs. negative candidates (HR 1.17; 95% CI 0.82–1.68). Comparable SCD risk was observed between articles with short- (OR 7.47; 95% CI 0.54–103.12) vs. long-term (OR 6.15; 95% CI 0.96–39.45) follow-up time.

Conclusion

LGE-CMR positivity was associated with an increased SCD risk; however, in CRT candidates, the difference in risk reduction between LGE positive vs. negative patients was statistically not significant, suggesting a role of reverse remodeling. LGE-CMR before device implantation could be crucial in identifying high-risk patients even in non-ischemic etiology. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Death, Sudden, CardiacDefibrillators, ImplantableCardiac Resynchronization TherapyContrast MediaGadoliniumMagnetic Resonance Imaging, CineMyocardiumHeart FailureHumansPredictive Value of TestsRisk FactorsRisk Assessment

Stichwörter der Autor:innen

Cardiac MRICardiac resynchronization therapyCardiovascular mortalityLGE-CMRScar burdenSudden cardiac death

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • Centre for Translational Medicine, Semmelweis University, Budapest, 1085, Hungary.
  • Heart and Vascular Center, Semmelweis University, 68 Városmajor Street, Budapest, 1122, Hungary.
  • Department of Cardiology, Military Hospital - State Health Centre, Budapest, Hungary.
  • Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
  • Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.
  • Department of Biostatistics, University of Veterinary Medicine, Budapest, Hungary.

Förderung

  • National Research, Development and Innovation Office
  • Semmelweis Egyetem
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
  • Semmelweis University

Zitieren

APA

Masszi, R., Zsigmond, E. J., Ehrenberger, R., Turan, C., Fehérvári, P., Teutsch, B., Molnár, Z., Drobni, Z., Vágó, H., Hegyi, P., Merkely, B., & Kosztin, A. (2024). Evaluating the predictive value of late gadolinium enhancement assessed by cardiac magnetic resonance on sudden cardiac death in patients selected for implantable cardioverter defibrillator and cardiac resynchronization therapy implantation: a systematic review and meta-analysis. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02441-2

Vancouver

Masszi R, Zsigmond EJ, Ehrenberger R, Turan C, Fehérvári P, Teutsch B, et al. Evaluating the predictive value of late gadolinium enhancement assessed by cardiac magnetic resonance on sudden cardiac death in patients selected for implantable cardioverter defibrillator and cardiac resynchronization therapy implantation: a systematic review and meta-analysis. Clinical Research in Cardiology. 2024. doi:10.1007/s00392-024-02441-2

BibTeX
@article{Masszi2024,
  author = {Masszi, Richárd and Zsigmond, Előd-János and Ehrenberger, Réka and Turan, Caner and Fehérvári, Péter and Teutsch, Brigitta and Molnár, Zsolt and Drobni, Zsófia and Vágó, Hajnalka and Hegyi, Péter and Merkely, Béla and Kosztin, Annamária},
  title = {Evaluating the predictive value of late gadolinium enhancement assessed by cardiac magnetic resonance on sudden cardiac death in patients selected for implantable cardioverter defibrillator and cardiac resynchronization therapy implantation: a systematic review and meta-analysis},
  journal = {Clinical Research in Cardiology},
  year = {2024},
  doi = {10.1007/s00392-024-02441-2}
}
Kostenlos starten →